{"Ticker": "IQV", "Company": "IQVIA", "Sector": "Health Care", "Updated": "2022-08-25", "Rating": [{"Date": "2022-08-25", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$300"}, {"Date": "2022-07-15", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Outperform", "Target_Change": "$256"}, {"Date": "2022-05-24", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Buy", "Target_Change": "$244"}, {"Date": "2022-04-29", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$231 to $255"}, {"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$235"}, {"Date": "2021-08-05", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$272"}, {"Date": "2021-04-16", "Rating": "Upgrade", "Organization": "Stephens", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$180 to $250"}, {"Date": "2021-03-08", "Rating": "Upgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Sector Weight to Overweight", "Target_Change": "$218"}, {"Date": "2021-03-03", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$220"}, {"Date": "2020-07-07", "Rating": "Initiated", "Organization": "Stephens", "Rating_Change": "Equal-Weight", "Target_Change": "$150"}, {"Date": "2020-03-02", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$190"}, {"Date": "2020-01-08", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$180"}, {"Date": "2020-01-07", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$185"}, {"Date": "2019-12-13", "Rating": "Upgrade", "Organization": "CFRA", "Rating_Change": "Sell to Hold", "Target_Change": ""}, {"Date": "2019-11-14", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": ""}, {"Date": "2019-06-21", "Rating": "Upgrade", "Organization": "Mizuho", "Rating_Change": "Neutral to Buy", "Target_Change": "$150 to $175"}, {"Date": "2019-05-28", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Outperform", "Target_Change": ""}, {"Date": "2019-01-18", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2018-10-09", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2018-10-02", "Rating": "Reiterated", "Organization": "Robert W. Baird", "Rating_Change": "Outperform", "Target_Change": "$143 to $146"}, {"Date": "2018-07-25", "Rating": "Upgrade", "Organization": "BofA/Merrill", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2018-07-25", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$128 to $150"}, {"Date": "2018-07-03", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Strong Buy", "Target_Change": ""}, {"Date": "2018-04-13", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2018-03-07", "Rating": "Upgrade", "Organization": "SunTrust", "Rating_Change": "Hold to Buy", "Target_Change": ""}]}